Latest On OncoSec Medical Incorporated (ONCS):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-16 17:15 EST | News | OncoSec Medical plunges 35% lower on sale of 1.4M shares of common stock | N/A |  |
| 2023-04-27 21:38 EST | News | OncoSec receives $3.9M in tax credits from NJEDA program | N/A | |
| 2023-04-11 01:47 EST | News | OncoSec rises 12% on $2M direct offering | N/A | |
| 2023-04-04 01:14 EST | News | OncoSec crashes ~60% after TAVO-EP, Keytruda combo fails phase 2 skin cancer trial | N/A | |
| 2022-11-30 21:44 EST | News | OncoSec Medical prices $3.5M stock offering | N/A | |
| 2022-11-23 17:30 EST | News | OncoSec provides updates on cancer programs in new filing | N/A | |
| 2022-11-11 14:41 EST | News | OncoSec jumps 19% after positive Phase 2 data for melanoma candidate | N/A | |
| 2022-11-08 16:55 EST | News | OncoSec stock plummets 26% on 1-for-22 reverse stock split | N/A | |
| 2022-10-04 19:44 EST | News | OncoSec to cut workforce by 45% as part of corporate restructuring | N/A | |
| 2022-04-29 10:19 EST | News | Robert Arch joins OncoSec Medical as CEO | N/A | |
| 2022-02-23 23:38 EST | News | OncoSec appoints new finance chief | N/A | |
| 2021-10-15 18:38 EST | News | BTIG assumes coverage of Immuno-oncology companies; OncoSec gains on Buy rating | N/A | |
| 2021-10-13 05:43 EST | News | Warning: ONCS is at high risk of performing badly | N/A | |
| 2021-09-30 19:57 EST | News | Warning: ONCS has been downgraded to Very Bearish | N/A | |
| 2021-09-23 08:52 EST | News | Warning: ONCS has been downgraded to Very Bearish. | N/A | |
| 2021-07-21 17:58 EST | News | OncoSec names Brian Leuthner as interim chief executive officer | N/A | |
| 2021-07-21 17:51 EST | News | OncoSec surges 20% after teaming up with Merck for late-stage TAVO/Keytruda trial | N/A | |
| 2021-07-21 17:50 EST | News | Aerpio Pharmaceuticals, GBS leads healthcare gainers; Virpax Pharmaceuticals, Nephros among major losers | N/A | |
| 2021-04-14 11:49 EST | News | OncoSec receives CE mark certification for its commercial electroporation device | N/A | |
| 2021-03-18 05:27 EST | Financials | Company financials have been released. | Neutral | |
| 2021-03-10 12:04 EST | Analyst Rating | The Analyst Target Price has increased from $8.13 to $8.5. | Buy | |
| 2021-02-23 18:41 EST | News | OncoSec receives $2.5M approval in NJEDA NOL Program Tax Benefits | N/A | |
| 2021-01-27 19:14 EST | News | Dosing underway in OncoSec's COVID-19 vaccine candidate study | N/A | |
| 2021-01-21 12:42 EST | News | OncoSec Medical prices $42M share offering | N/A | |
| 2021-01-20 21:46 EST | News | OncoSec Medical readies underwritten public offering | N/A | |
| 2021-01-19 15:58 EST | News | Sirtex Medical provides collaboration update with Oncosec | N/A | |
| 2021-01-08 20:53 EST | News | Dosing underway in OncoSec's Tavo combo trial in skin cancer | N/A | |
| 2020-12-14 08:26 EST | Earnings Estimate | An EPS average of -$0.36 is estimated for the quarter ending on April 30, 2021. | Buy | |
| 2020-12-13 04:40 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-26 21:06 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-18 20:51 EST | News | OncoSec: Undervalued And Continuing To Make Progress | N/A | |
| 2020-11-10 12:44 EST | Analyst Rating | The Analyst Target Price has increased from $7.38 to $8.13. | Buy | |
| 2020-11-09 15:56 EST | News | OncoSec drops 11% despite positive data from TAVO + Merck's Keytruda in metastatic melanoma | N/A | |
| 2020-11-09 15:55 EST | News | Second tier COVID-19 vaccine developers under pressure on positive Pfizer/BioNTech data | N/A | |
| 2020-11-08 00:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 16:43 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-03 20:09 EST | Insider Trade | Daniel J. O'Connor has directly disposed of 3,280 shares and currently holds 102,682 shares. | Sell | |
| 2020-11-02 04:28 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-30 14:09 EST | Earnings Estimate | An EPS average of -$1.13 is estimated for the 2022 year. | Sell | |
| 2020-10-30 14:09 EST | Earnings Estimate | An EPS average of -$0.39 is estimated for the quarter ending on January 31, 2021. | Sell | |
| 2020-10-06 19:03 EST | News | OncoSec secures new patent in U.S.; shares up 8% | N/A | |
| 2020-09-26 13:38 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 05:44 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-21 17:50 EST | Insider Trade | Grand Pharmaceutical & Healthcare Holdings Ltd China has indirectly acquired of 399,800 shares. | Buy | |
| 2020-08-21 17:50 EST | Insider Trade | Grand Pharmaceutical & Healthcare Holdings Ltd China has indirectly acquired of 1,999,000 shares. | Buy | |
| 2020-08-17 11:10 EST | News | OncoSec Medical intends to offer common stock | N/A | |
| 2020-08-17 11:10 EST | News | OncoSec Medical prices $15M-share offering | N/A | |
| 2020-08-14 09:43 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 13:27 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-04 21:41 EST | Insider Trade | Daniel J. O'Connor has directly disposed of 3,133 shares and currently holds 105,962 shares. | Sell | |
About OncoSec Medical Incorporated (ONCS):
OncoSec Medical Incorporated, a biotechnology company, focuses on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target and attack cancer. The company's lead product candidate is ImmunoPulse IL-12 that uses electroporation device to deliver a DNA-encoded interleukin-12 (IL-12) for reversing the immunosuppressive microenvironment in the treated tumor. It is also developing ImmunoPulse IL-12 with KEYTRUDA in patients with advanced melanoma that is in Phase IIb clinical trials (KEYNOTE-695) and advanced or metastatic triple negative breast cancer (TNBC), which is in Phase II clinical trials (KEYNOTE-890); ImmunoPulse IL-12 and KEYTRUDA in patients with advanced or metastatic melanoma that has completed Phase II clinical trials; and ImmunoPulse IL-12 monotherapy in patients with metastatic melanoma, which has completed the Phase II clinical trials. In addition, the company is developing monotherapy biomarker study in patients with advanced or metastatic TNBC that has completed the Phase II clinical trials; and new DNA-encoded therapeutic candidates and tumor indications to treat deep visceral lesions, such as liver, lung, bladder, pancreatic, and other visceral lesions. It has clinical trial collaborations with Merck & Co., Inc. and its subsidiary in connection with the KEYNOTE-695 and KEYNOTE-890 studies; a research collaboration with Duke University's Center for Applied Therapeutics to evaluate enhanced IL-12 DNA-plasmid; a research collaboration with Roswell Park Comprehensive Cancer Center to evaluate the use of Roswell Park's intravital microscopy and enhanced IL-12 DNA-plasmid; and collaboration with Providence Cancer Institute. The company was formerly known as NetVentory Solutions Inc. and changed its name to OncoSec Medical Incorporated in March 2011. OncoSec Medical Incorporated was founded in 2008 and is headquartered in Pennington, New Jersey.
General
- Name OncoSec Medical Incorporated
- Symbol ONCS
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 42
- Last Split Factor1:10
- Last Split Date2019-05-21
- Fiscal Year EndJuly
- IPO Date2011-03-31
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://oncosec.com
View More
Valuation
- Price/Book (Most Recent Quarter) 4.75
View More
Financials
- Most Recent Quarter 2021-01-31
- Current Year EPS Estimate -$1.54
- Next Year EPS Estimate -$1.11
- Return on Assets -61%
- Return on Equity -167%
- Earnings Per Share -$5.93
- Revenue Per Share $0
- Quarterly Earnings Growth 0%
View More
Highlights
- Market Capitalization 213.3 million
- EBITDA -34853636
- Analyst Target Price $8.5
- Book Value Per Share $1.32
View More
Share Statistics
- Shares Outstanding 37.16 million
- Shares Float 13.97 million
- % Held by Insiders 5671%
- % Held by Institutions 13.9%
- Shares Short 393396
- Shares Short Prior Month 404822
- Short Ratio 1.28
- Short % of Float 2%
- Short % of Shares Outstanding 1%
View More
Technicals
- Beta 2.48
- 52 Week High $8.16
- 52 Week Low $1.05
- 50 Day Moving Average 6.39
- 200 Day Moving Average 5.24
View More
Dividends
- Dividend Date 2019-05-21
- ExDividend Date N/A
- Dividend Yield 0%
View More
OncoSec Medical Incorporated (ONCS) Dividend Calendar:
ONCS's last dividend payment was made to shareholders on May 21, 2019.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
OncoSec Medical Incorporated (ONCS) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2021-01-31 | 2021-01-31 | $N/A | -$0.37 | -$0.36 | -2.78% |
| 2020-10-31 | 2020-12-11 | $N/A | -$0.49 | -$0.40 | -22.5% |
| 2020-07-31 | 2020-10-28 | $N/A | -$0.25 | -$0.47 | 46.81% |
| 2020-04-30 | 2020-06-15 | $N/A | -$0.45 | -$0.55 | 18.18% |
| 2020-01-31 | 2020-03-16 | $N/A | -$1.27 | -$0.67 | -89.55% |
| 2019-10-31 | 2019-12-13 | $N/A | -$0.92 | -$0.72 | -28.67% |
| 2019-07-31 | 2019-10-28 | $N/A | -$0.58 | -$0.84 | 30.95% |
| 2019-04-30 | 2019-06-14 | $N/A | -$1.03 | -$1.36 | 24.26% |
| 2019-01-31 | 2019-03-08 | $N/A | -$1.30 | -$1.60 | 18.75% |
| 2018-10-31 | 2018-12-14 | $-12134 | -$1.40 | -$1.60 | 12.5% |
| 2018-07-31 | 2018-10-19 | $N/A | -$2.30 | -$1.70 | -35.29% |
| 2018-04-30 | 2018-06-13 | $N/A | -$2.00 | -$1.80 | -11.11% |
| 2018-01-31 | 2018-03-09 | $N/A | -$3.10 | -$2.70 | -14.81% |
| 2017-10-31 | 2017-12-07 | $N/A | -$2.60 | -$2.10 | -23.81% |
| 2017-07-31 | 2017-10-25 | $N/A | -$2.80 | -$2.43 | -15.07% |
| 2017-04-30 | 2017-06-01 | $N/A | -$2.20 | -$2.73 | 19.51% |
| 2017-01-31 | 2017-03-16 | $N/A | -$2.70 | -$3.23 | 16.49% |
| 2016-10-31 | 2016-12-08 | $N/A | -$2.90 | -$3.60 | 19.44% |
| 2016-07-31 | 2016-10-13 | $N/A | -$3.90 | -$3.73 | -4.7% |
| 2016-04-30 | 2016-06-09 | $N/A | -$3.70 | -$4.33 | 14.61% |
| 2016-01-31 | 2016-03-08 | $N/A | -$4.20 | -$4.47 | 5.97% |
| 2015-10-31 | 2015-12-08 | $N/A | -$0.47 | -$0.48 | 2.08% |
| 2015-07-31 | 2015-10-14 | $N/A | -$0.48 | -$0.40 | -20% |
| 2015-04-30 | 2015-06-09 | $N/A | -$0.48 | -$0.40 | -20% |
| 2015-01-31 | 2015-03-12 | $N/A | -$0.40 | -$0.40 | 0% |
| 2014-10-31 | 2014-12-08 | $N/A | -$0.40 | -$0.40 | 0% |
| 2014-07-31 | 2014-10-08 | $N/A | -$0.20 | -$0.40 | 50% |
| 2014-04-30 | 2014-06-13 | $N/A | -$4.00 | -$2.00 | -100% |
| 2014-01-31 | 2014-03-14 | $N/A | -$2.00 | -$2.00 | 0% |
| 2013-10-31 | 2013-12-16 | $N/A | -$2.00 | -$4.00 | 50% |
| 2013-07-31 | 2013-09-27 | $N/A | -$3.00 | -$4.00 | 25% |
| 2013-04-30 | 2013-07-03 | $N/A | -$2.93 | ||
| 2013-01-31 | 2013-04-03 | $N/A | -$3.15 | ||
| 2012-10-31 | 2013-01-02 | $N/A | -$4.61 | ||
| 2012-07-31 | 2012-10-15 | $N/A | -$6.00 | -$4.00 | -50% |
| 2012-04-30 | 2012-06-27 | $N/A | -$2.38 | ||
| 2012-01-31 | 2012-03-28 | $N/A | -$9.40 | ||
| 2011-10-31 | 2011-12-28 | $N/A | $9.53 | ||
| 2011-07-31 | 2011-10-20 | $N/A | -$10.28 | -$2.00 | -413.84% |
| 2011-04-30 | 2011-06-29 | $N/A | -$1.62 | ||
| 2011-01-31 | 2011-01-31 | $N/A | -$0.01 | ||
| 2010-10-31 | 2010-10-31 | $N/A | -$0.01 | ||
| 2010-07-31 | 2010-07-31 | -$0.06 | |||
| 2010-04-30 | 2010-04-30 | -$0.01 |
OncoSec Medical Incorporated (ONCS) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
OncoSec Medical Incorporated (ONCS) Chart:
OncoSec Medical Incorporated (ONCS) News:
Below you will find a list of latest news for OncoSec Medical Incorporated (ONCS) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
OncoSec Medical Incorporated (ONCS) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
OncoSec Medical Incorporated (ONCS) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-23 | S-3/A | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1444307/000149315220011612/0001493152-20-011612-index.htm |
| 2020-02-13 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1444307/000000000020001392/0000000000-20-001392-index.htm |
| 2020-03-10 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1444307/000000000020002139/0000000000-20-002139-index.htm |
| 2020-04-20 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1444307/000000000020003392/0000000000-20-003392-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1444307/000089914019000234/0000899140-19-000234-index.htm |
| 2020-02-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000089924320004957/0000899243-20-004957-index.htm |
| 2020-02-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000089924320004959/0000899243-20-004959-index.htm |
| 2020-02-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000089924320004960/0000899243-20-004960-index.htm |
| 2020-02-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000089924320004961/0000899243-20-004961-index.htm |
| 2020-02-19 | 3/A | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000089924320005128/0000899243-20-005128-index.htm |
| 2020-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000089924320023209/0000899243-20-023209-index.htm |
| 2019-06-03 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1444307/000091957419003943/0000919574-19-003943-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1444307/000101359419000181/0001013594-19-000181-index.htm |
| 2020-02-18 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1444307/000119312520040677/0001193125-20-040677-index.htm |
| 2019-07-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000121390019013045/0001213900-19-013045-index.htm |
| 2019-07-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000121390019013229/0001213900-19-013229-index.htm |
| 2019-10-15 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1444307/000121390019020321/0001213900-19-020321-index.htm |
| 2019-10-18 | PREC14A | Preliminary proxy statements, contested solicitations | https://www.sec.gov/Archives/edgar/data/1444307/000121390019020613/0001213900-19-020613-index.htm |
| 2019-10-22 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1444307/000121390019020780/0001213900-19-020780-index.htm |
| 2019-10-31 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1444307/000121390019021637/0001213900-19-021637-index.htm |
| 2019-11-01 | PRRN14A | Non-management revised preliminary proxy soliciting materials, contested and otherwise | https://www.sec.gov/Archives/edgar/data/1444307/000121390019021805/0001213900-19-021805-index.htm |
| 2019-11-15 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390019023700/0001213900-19-023700-index.htm |
| 2019-11-20 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390019024198/0001213900-19-024198-index.htm |
| 2019-11-27 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390019024918/0001213900-19-024918-index.htm |
| 2019-12-03 | PRRN14A | Non-management revised preliminary proxy soliciting materials, contested and otherwise | https://www.sec.gov/Archives/edgar/data/1444307/000121390019025186/0001213900-19-025186-index.htm |
| 2019-12-04 | PRRN14A | Non-management revised preliminary proxy soliciting materials, contested and otherwise | https://www.sec.gov/Archives/edgar/data/1444307/000121390019025333/0001213900-19-025333-index.htm |
| 2019-12-05 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390019025401/0001213900-19-025401-index.htm |
| 2019-12-06 | DEFN14A | Definitive proxy statement filed by non-management | https://www.sec.gov/Archives/edgar/data/1444307/000121390019025467/0001213900-19-025467-index.htm |
| 2019-12-06 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390019025520/0001213900-19-025520-index.htm |
| 2019-12-06 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390019025541/0001213900-19-025541-index.htm |
| 2019-12-18 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390019026401/0001213900-19-026401-index.htm |
| 2019-12-18 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390019026403/0001213900-19-026403-index.htm |
| 2019-12-18 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390019026439/0001213900-19-026439-index.htm |
| 2019-12-18 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390019026444/0001213900-19-026444-index.htm |
| 2019-12-18 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390019026446/0001213900-19-026446-index.htm |
| 2019-12-20 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390019026674/0001213900-19-026674-index.htm |
| 2019-12-20 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390019026678/0001213900-19-026678-index.htm |
| 2019-12-26 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390019026985/0001213900-19-026985-index.htm |
| 2019-12-26 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390019026986/0001213900-19-026986-index.htm |
| 2019-12-30 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390019027174/0001213900-19-027174-index.htm |
| 2019-12-30 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390019027180/0001213900-19-027180-index.htm |
| 2019-12-30 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390019027185/0001213900-19-027185-index.htm |
| 2020-01-08 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390020000423/0001213900-20-000423-index.htm |
| 2020-01-08 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390020000448/0001213900-20-000448-index.htm |
| 2020-01-08 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390020000450/0001213900-20-000450-index.htm |
| 2020-01-13 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390020000805/0001213900-20-000805-index.htm |
| 2020-01-14 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1444307/000121390020000982/0001213900-20-000982-index.htm |
| 2020-01-14 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390020000990/0001213900-20-000990-index.htm |
| 2020-01-14 | SC TO-C | Written communication relating to an issuer or third party | https://www.sec.gov/Archives/edgar/data/1444307/000121390020000994/0001213900-20-000994-index.htm |
| 2020-01-14 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390020000998/0001213900-20-000998-index.htm |
| 2020-01-14 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390020001006/0001213900-20-001006-index.htm |
| 2020-01-15 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390020001051/0001213900-20-001051-index.htm |
| 2020-01-15 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390020001086/0001213900-20-001086-index.htm |
| 2020-01-15 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390020001090/0001213900-20-001090-index.htm |
| 2020-01-15 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390020001092/0001213900-20-001092-index.htm |
| 2020-01-15 | SC TO-C | Written communication relating to an issuer or third party | https://www.sec.gov/Archives/edgar/data/1444307/000121390020001133/0001213900-20-001133-index.htm |
| 2020-01-17 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390020001275/0001213900-20-001275-index.htm |
| 2020-01-17 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390020001280/0001213900-20-001280-index.htm |
| 2020-01-17 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390020001287/0001213900-20-001287-index.htm |
| 2020-01-17 | SC TO-C | Written communication relating to an issuer or third party | https://www.sec.gov/Archives/edgar/data/1444307/000121390020001323/0001213900-20-001323-index.htm |
| 2020-01-17 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390020001326/0001213900-20-001326-index.htm |
| 2020-01-21 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390020001467/0001213900-20-001467-index.htm |
| 2020-01-27 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390020001915/0001213900-20-001915-index.htm |
| 2020-01-27 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390020001920/0001213900-20-001920-index.htm |
| 2020-01-27 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390020001929/0001213900-20-001929-index.htm |
| 2020-01-27 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390020001931/0001213900-20-001931-index.htm |
| 2020-01-29 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390020002095/0001213900-20-002095-index.htm |
| 2020-02-03 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390020002396/0001213900-20-002396-index.htm |
| 2020-02-03 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390020002399/0001213900-20-002399-index.htm |
| 2020-02-03 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000121390020002400/0001213900-20-002400-index.htm |
| 2019-05-30 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1444307/000138713119004079/0001387131-19-004079-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1444307/000138713120001697/0001387131-20-001697-index.htm |
| 2018-10-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1444307/000149315218014268/0001493152-18-014268-index.htm |
| 2018-10-09 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1444307/000149315218014272/0001493152-18-014272-index.htm |
| 2018-10-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315218014645/0001493152-18-014645-index.htm |
| 2018-10-19 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1444307/000149315218014674/0001493152-18-014674-index.htm |
| 2018-10-19 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1444307/000149315218014675/0001493152-18-014675-index.htm |
| 2018-10-29 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1444307/000149315218014930/0001493152-18-014930-index.htm |
| 2018-11-02 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1444307/000149315218015153/0001493152-18-015153-index.htm |
| 2018-11-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1444307/000149315218015157/0001493152-18-015157-index.htm |
| 2018-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1444307/000149315218015235/0001493152-18-015235-index.htm |
| 2018-11-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315218015311/0001493152-18-015311-index.htm |
| 2018-11-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1444307/000149315218015421/0001493152-18-015421-index.htm |
| 2018-11-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315218015422/0001493152-18-015422-index.htm |
| 2018-11-08 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1444307/000149315218015476/0001493152-18-015476-index.htm |
| 2018-11-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315218015582/0001493152-18-015582-index.htm |
| 2018-11-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315218016700/0001493152-18-016700-index.htm |
| 2018-12-11 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1444307/000149315218017341/0001493152-18-017341-index.htm |
| 2018-12-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1444307/000149315218017343/0001493152-18-017343-index.htm |
| 2018-12-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1444307/000149315218017545/0001493152-18-017545-index.htm |
| 2018-12-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315218017619/0001493152-18-017619-index.htm |
| 2018-12-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1444307/000149315218017859/0001493152-18-017859-index.htm |
| 2018-12-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315218018024/0001493152-18-018024-index.htm |
| 2018-12-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315218018025/0001493152-18-018025-index.htm |
| 2019-01-04 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315219000204/0001493152-19-000204-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315219000205/0001493152-19-000205-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315219000206/0001493152-19-000206-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315219000207/0001493152-19-000207-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315219000208/0001493152-19-000208-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315219000209/0001493152-19-000209-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315219000210/0001493152-19-000210-index.htm |
| 2019-01-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315219000773/0001493152-19-000773-index.htm |
| 2019-02-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1444307/000149315219001233/0001493152-19-001233-index.htm |
| 2019-02-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315219001271/0001493152-19-001271-index.htm |
| 2019-03-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1444307/000149315219003049/0001493152-19-003049-index.htm |
| 2019-03-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1444307/000149315219004246/0001493152-19-004246-index.htm |
| 2019-03-29 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1444307/000149315219004257/0001493152-19-004257-index.htm |
| 2019-04-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315219005630/0001493152-19-005630-index.htm |
| 2019-04-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1444307/000149315219005884/0001493152-19-005884-index.htm |
| 2019-04-26 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315219006029/0001493152-19-006029-index.htm |
| 2019-04-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315219006033/0001493152-19-006033-index.htm |
| 2019-05-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315219006293/0001493152-19-006293-index.htm |
| 2019-05-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1444307/000149315219007911/0001493152-19-007911-index.htm |
| 2019-05-22 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1444307/000149315219008049/0001493152-19-008049-index.htm |
| 2019-05-23 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1444307/000149315219008116/0001493152-19-008116-index.htm |
| 2019-05-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1444307/000149315219008118/0001493152-19-008118-index.htm |
| 2019-05-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1444307/000149315219008279/0001493152-19-008279-index.htm |
| 2019-06-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1444307/000149315219008778/0001493152-19-008778-index.htm |
| 2019-06-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1444307/000149315219008906/0001493152-19-008906-index.htm |
| 2019-06-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1444307/000149315219009215/0001493152-19-009215-index.htm |
| 2019-07-02 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1444307/000149315219010176/0001493152-19-010176-index.htm |
| 2019-07-12 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1444307/000149315219010549/0001493152-19-010549-index.htm |
| 2019-07-12 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315219010550/0001493152-19-010550-index.htm |
| 2019-07-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1444307/000149315219010614/0001493152-19-010614-index.htm |
| 2019-07-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315219010839/0001493152-19-010839-index.htm |
| 2019-08-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315219011572/0001493152-19-011572-index.htm |
| 2019-08-23 | DEFR14A | Revised definitive proxy soliciting materials | https://www.sec.gov/Archives/edgar/data/1444307/000149315219013321/0001493152-19-013321-index.htm |
| 2019-08-23 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1444307/000149315219013326/0001493152-19-013326-index.htm |
| 2019-09-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1444307/000149315219013812/0001493152-19-013812-index.htm |
| 2019-10-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1444307/000149315219015370/0001493152-19-015370-index.htm |
| 2019-10-16 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1444307/000149315219015584/0001493152-19-015584-index.htm |
| 2019-10-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315219015722/0001493152-19-015722-index.htm |
| 2019-10-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1444307/000149315219015741/0001493152-19-015741-index.htm |
| 2019-10-28 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1444307/000149315219016036/0001493152-19-016036-index.htm |
| 2019-11-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315219016362/0001493152-19-016362-index.htm |
| 2019-11-12 | PRER14A | Preliminary Proxy Soliciting materials | https://www.sec.gov/Archives/edgar/data/1444307/000149315219016850/0001493152-19-016850-index.htm |
| 2019-11-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1444307/000149315219018403/0001493152-19-018403-index.htm |
| 2019-11-26 | PRER14A | Preliminary Proxy Soliciting materials | https://www.sec.gov/Archives/edgar/data/1444307/000149315219018404/0001493152-19-018404-index.htm |
| 2019-11-27 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1444307/000149315219018522/0001493152-19-018522-index.htm |
| 2019-12-02 | DEFC14A | Definitive proxy statement, contested solicitations | https://www.sec.gov/Archives/edgar/data/1444307/000149315219018579/0001493152-19-018579-index.htm |
| 2019-12-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1444307/000149315219018607/0001493152-19-018607-index.htm |
| 2019-12-02 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315219018608/0001493152-19-018608-index.htm |
| 2019-12-02 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315219018610/0001493152-19-018610-index.htm |
| 2019-12-02 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315219018648/0001493152-19-018648-index.htm |
| 2019-12-02 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315219018649/0001493152-19-018649-index.htm |
| 2019-12-03 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315219018696/0001493152-19-018696-index.htm |
| 2019-12-04 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315219018710/0001493152-19-018710-index.htm |
| 2019-12-05 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315219018798/0001493152-19-018798-index.htm |
| 2019-12-05 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315219018802/0001493152-19-018802-index.htm |
| 2019-12-06 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315219018860/0001493152-19-018860-index.htm |
| 2019-12-06 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315219018864/0001493152-19-018864-index.htm |
| 2019-12-09 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315219018881/0001493152-19-018881-index.htm |
| 2019-12-09 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315219018882/0001493152-19-018882-index.htm |
| 2019-12-09 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315219018921/0001493152-19-018921-index.htm |
| 2019-12-09 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315219018922/0001493152-19-018922-index.htm |
| 2019-12-10 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315219018978/0001493152-19-018978-index.htm |
| 2019-12-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1444307/000149315219019066/0001493152-19-019066-index.htm |
| 2019-12-12 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315219019068/0001493152-19-019068-index.htm |
| 2019-12-12 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315219019111/0001493152-19-019111-index.htm |
| 2019-12-12 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315219019112/0001493152-19-019112-index.htm |
| 2019-12-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1444307/000149315219019194/0001493152-19-019194-index.htm |
| 2019-12-17 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315219019383/0001493152-19-019383-index.htm |
| 2019-12-18 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315219019415/0001493152-19-019415-index.htm |
| 2019-12-20 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315219019494/0001493152-19-019494-index.htm |
| 2019-12-20 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315219019538/0001493152-19-019538-index.htm |
| 2019-12-26 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315219019703/0001493152-19-019703-index.htm |
| 2019-12-26 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315219019737/0001493152-19-019737-index.htm |
| 2019-12-30 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315219019883/0001493152-19-019883-index.htm |
| 2020-01-06 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315220000181/0001493152-20-000181-index.htm |
| 2020-01-06 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315220000254/0001493152-20-000254-index.htm |
| 2020-01-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1444307/000149315220000296/0001493152-20-000296-index.htm |
| 2020-01-16 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315220000657/0001493152-20-000657-index.htm |
| 2020-01-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1444307/000149315220000658/0001493152-20-000658-index.htm |
| 2020-01-16 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315220000660/0001493152-20-000660-index.htm |
| 2020-01-21 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315220000820/0001493152-20-000820-index.htm |
| 2020-01-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315220000866/0001493152-20-000866-index.htm |
| 2020-01-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1444307/000149315220000873/0001493152-20-000873-index.htm |
| 2020-01-21 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315220000885/0001493152-20-000885-index.htm |
| 2020-01-24 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315220001063/0001493152-20-001063-index.htm |
| 2020-01-27 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315220001180/0001493152-20-001180-index.htm |
| 2020-01-28 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315220001202/0001493152-20-001202-index.htm |
| 2020-01-28 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315220001231/0001493152-20-001231-index.htm |
| 2020-01-28 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315220001265/0001493152-20-001265-index.htm |
| 2020-01-31 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315220001417/0001493152-20-001417-index.htm |
| 2020-01-31 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315220001447/0001493152-20-001447-index.htm |
| 2020-02-03 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315220001506/0001493152-20-001506-index.htm |
| 2020-02-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315220001537/0001493152-20-001537-index.htm |
| 2020-02-07 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315220001729/0001493152-20-001729-index.htm |
| 2020-02-07 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315220001735/0001493152-20-001735-index.htm |
| 2020-02-07 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1444307/000149315220001803/0001493152-20-001803-index.htm |
| 2020-02-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1444307/000149315220001841/0001493152-20-001841-index.htm |
| 2020-02-12 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315220002037/0001493152-20-002037-index.htm |
| 2020-02-27 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1444307/000149315220003087/0001493152-20-003087-index.htm |
| 2020-03-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1444307/000149315220003620/0001493152-20-003620-index.htm |
| 2020-03-16 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1444307/000149315220003958/0001493152-20-003958-index.htm |
| 2020-03-30 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1444307/000149315220005297/0001493152-20-005297-index.htm |
| 2020-04-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1444307/000149315220006753/0001493152-20-006753-index.htm |
| 2020-04-20 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1444307/000149315220006776/0001493152-20-006776-index.htm |
| 2020-04-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315220006875/0001493152-20-006875-index.htm |
| 2020-04-30 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1444307/000149315220007458/0001493152-20-007458-index.htm |
| 2020-05-01 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315220007522/0001493152-20-007522-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315220007676/0001493152-20-007676-index.htm |
| 2020-05-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1444307/000149315220010178/0001493152-20-010178-index.htm |
| 2020-05-29 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1444307/000149315220010182/0001493152-20-010182-index.htm |
| 2020-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315220010491/0001493152-20-010491-index.htm |
| 2020-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315220010495/0001493152-20-010495-index.htm |
| 2020-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315220010498/0001493152-20-010498-index.htm |
| 2020-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315220010500/0001493152-20-010500-index.htm |
| 2020-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315220010502/0001493152-20-010502-index.htm |
| 2020-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315220010504/0001493152-20-010504-index.htm |
| 2020-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315220010506/0001493152-20-010506-index.htm |
| 2020-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315220010508/0001493152-20-010508-index.htm |
| 2020-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315220010510/0001493152-20-010510-index.htm |
| 2020-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315220010512/0001493152-20-010512-index.htm |
| 2020-06-15 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1444307/000149315220011123/0001493152-20-011123-index.htm |
| 2020-06-23 | S-3/A | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1444307/000149315220011612/0001493152-20-011612-index.htm |
| 2020-06-24 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1444307/000149315220011728/0001493152-20-011728-index.htm |
| 2020-07-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1444307/000149315220014047/0001493152-20-014047-index.htm |
| 2020-08-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315220014643/0001493152-20-014643-index.htm |
| 2020-08-05 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315220014739/0001493152-20-014739-index.htm |
| 2020-08-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315220014742/0001493152-20-014742-index.htm |
| 2020-08-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1444307/000149315220016033/0001493152-20-016033-index.htm |
| 2020-08-17 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1444307/000149315220016042/0001493152-20-016042-index.htm |
| 2020-08-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315220016792/0001493152-20-016792-index.htm |
| 2020-08-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315220016793/0001493152-20-016793-index.htm |
| 2020-08-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315220016794/0001493152-20-016794-index.htm |
| 2020-09-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315220017930/0001493152-20-017930-index.htm |
| 2020-09-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315220017931/0001493152-20-017931-index.htm |
| 2020-09-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315220017932/0001493152-20-017932-index.htm |
| 2020-09-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315220017933/0001493152-20-017933-index.htm |
| 2020-10-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1444307/000149315220019371/0001493152-20-019371-index.htm |
| 2020-10-28 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1444307/000149315220020071/0001493152-20-020071-index.htm |
| 2020-10-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1444307/000149315220020139/0001493152-20-020139-index.htm |
| 2020-11-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000149315220020427/0001493152-20-020427-index.htm |
| 2018-10-17 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1444307/000161577418011014/0001615774-18-011014-index.htm |
| 2018-12-11 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1444307/000161577418014251/0001615774-18-014251-index.htm |
| 2018-12-11 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000161577418014253/0001615774-18-014253-index.htm |
| 2019-05-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000161577419008423/0001615774-19-008423-index.htm |
| 2019-05-28 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1444307/000161577419008530/0001615774-19-008530-index.htm |
| 2019-05-30 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1444307/000161577419008654/0001615774-19-008654-index.htm |
| 2020-06-26 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1444307/999999999520001662/9999999995-20-001662-index.htm |
OncoSec Medical Incorporated (ONCS) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of OncoSec Medical Incorporated (ONCS). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 5671%Institutional Ownership: 1390%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-11-02 | Daniel J. O'Connor | CEO and President | Sell | 3,280.00 | 3.79 | 12,431.20 | 102,682.00 | https://www.sec.gov/Archives/edgar/data/1444307/000149315220020427/0001493152-20-020427-index.htm |
| 2019-05-22 | Alpha Holdings, Inc. | Director | Buy | 491,000.00 | 3.14 | 1,541,740.00 | 10,491,000.00 | https://www.sec.gov/Archives/edgar/data/1444307/000161577419008423/0001615774-19-008423-index.htm |
| 2020-07-31 | Daniel J. O'Connor | CEO and President | Sell | 3,133.00 | 4.20 | 13,158.60 | 105,962.00 | https://www.sec.gov/Archives/edgar/data/1444307/000149315220014643/0001493152-20-014643-index.htm |
| 2020-08-19 | Grand Pharmaceutical & Healthcare Holdings Ltd China | 10% Share Holder | Buy | 1,999,000.00 | 3.25 | 6,496,750.00 | 11,999,000.00 | https://www.sec.gov/Archives/edgar/data/1444307/000089924320023209/0000899243-20-023209-index.htm |
| 2018-11-07 | JAMES M DEMESA | Director | Buy | 1,500.00 | 0.91 | 1,365.00 | 14,001.00 | https://www.sec.gov/Archives/edgar/data/1444307/000149315218016700/0001493152-18-016700-index.htm |
| 2019-07-15 | Alpha Holdings, Inc. | Director | Buy | 30,000.00 | 2.22 | 66,600.00 | 1,521,000.00 | https://www.sec.gov/Archives/edgar/data/1444307/000121390019013045/0001213900-19-013045-index.htm |
| 2020-05-29 | Daniel J. O'Connor | CEO and President | Buy | 90,580.00 | 153,566.00 | https://www.sec.gov/Archives/edgar/data/1444307/000149315220010500/0001493152-20-010500-index.htm | ||
| 2019-07-16 | Alpha Holdings, Inc. | Director | Buy | 60,000.00 | 2.34 | 140,400.00 | 1,581,000.00 | https://www.sec.gov/Archives/edgar/data/1444307/000121390019013045/0001213900-19-013045-index.htm |
| 2019-07-17 | Alpha Holdings, Inc. | Director | Buy | 30,000.00 | 2.57 | 77,100.00 | 1,611,000.00 | https://www.sec.gov/Archives/edgar/data/1444307/000121390019013229/0001213900-19-013229-index.htm |
| 2018-11-20 | JAMES M DEMESA | Director | Buy | 7,000.00 | 0.80 | 5,600.00 | 21,001.00 | https://www.sec.gov/Archives/edgar/data/1444307/000149315218016700/0001493152-18-016700-index.htm |
| 2018-12-17 | JAMES M DEMESA | Director | Buy | 1,500.00 | 0.77 | 1,155.00 | 22,501.00 | https://www.sec.gov/Archives/edgar/data/1444307/000149315218017619/0001493152-18-017619-index.htm |
| 2020-08-19 | Grand Pharmaceutical & Healthcare Holdings Ltd China | 10% Share Holder | Buy | 399,800.00 | 3.25 | 1,299,350.00 | 2,399,800.00 | https://www.sec.gov/Archives/edgar/data/1444307/000089924320023209/0000899243-20-023209-index.htm |
| 2020-05-29 | Robert J DelAversano | Principal Accounting Officer | Buy | 25,362.00 | 25,362.00 | https://www.sec.gov/Archives/edgar/data/1444307/000149315220010512/0001493152-20-010512-index.htm | ||
| 2018-11-07 | Daniel J. O'Connor | CEO & President | Buy | 10,000.00 | 0.91 | 9,100.00 | 26,667.00 | https://www.sec.gov/Archives/edgar/data/1444307/000149315218015311/0001493152-18-015311-index.htm |
| 2020-01-16 | Sara Bonstein | CFO/COO | Sell | 1,351.00 | 2.08 | 2,810.08 | 41,389.00 | https://www.sec.gov/Archives/edgar/data/1444307/000149315220000866/0001493152-20-000866-index.htm |
| 2019-10-16 | Sara Bonstein | CFO/COO | Sell | 1,111.00 | 2.01 | 2,233.11 | 42,740.00 | https://www.sec.gov/Archives/edgar/data/1444307/000149315219015722/0001493152-19-015722-index.htm |
| 2020-04-17 | AVTAR S DHILLON | Director | Buy | 12,500.00 | 1.55 | 19,375.00 | 62,052.00 | https://www.sec.gov/Archives/edgar/data/1444307/000149315220006875/0001493152-20-006875-index.htm |
| 2020-04-30 | Daniel J. O'Connor | CEO and President | Sell | 3,075.00 | 1.79 | 5,504.25 | 62,986.00 | https://www.sec.gov/Archives/edgar/data/1444307/000149315220007676/0001493152-20-007676-index.htm |
| 2020-01-31 | Daniel J. O'Connor | CEO and President | Sell | 2,654.00 | 1.96 | 5,201.84 | 66,061.00 | https://www.sec.gov/Archives/edgar/data/1444307/000149315220001537/0001493152-20-001537-index.htm |
| 2019-10-31 | Daniel J. O'Connor | CEO and President | Sell | 2,128.00 | 2.16 | 4,596.48 | 68,715.00 | https://www.sec.gov/Archives/edgar/data/1444307/000149315219016362/0001493152-19-016362-index.htm |
| 2018-12-24 | Daniel J. O'Connor | CEO and President | Buy | 750,000.00 | 776,667.00 | https://www.sec.gov/Archives/edgar/data/1444307/000149315218018024/0001493152-18-018024-index.htm |